20.08.2025 • Topics

Beacons of the Start-up Scene, part 5: MIR Insight

Tapping into Future-oriented Synergies of Data Analysis in the Materials Sector

Interview mit Bjol R. Frenkenberger, MIR Insight

Since its launch in 2019, the CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has provided more than 100 start-ups from over 15 countries with the opportunity to present their innovative ideas, products and technologies to a broad target group. We are taking this milestone as an opportunity to look back at some of the start-up stories of the past six years and highlight their development. 

In this issue: MIR Insight. Founded in 2021 and based in Oslo, Norway, the company offers its customers data-driven forecasts created with the help of AI for accurate, dynamic demand forecasting. Co-founder and CEO Bjol R. Frenkenberger explainswhat has happened since its launch in December 2022 .

Continue with login

No account yet?

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Register

Company

MIR Insight AS

Gaustadalléen 21
0349 Oslo
Norway

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read